Prescriptions Ebook

Prescription Freedom: Natural Remedies To Live Drug Free

Prescription freedom is a product that helps individuals free up themselves from drug prescriptions. It is based on ancient natural solutions and applicable to all people irrespective of age and gender. It is a product of Kevin Christianson, once a victim of drug prescriptions but now free from such chains. The ancient remedies recommended can quickly give you power and reverse any kind of illness that plagues your heart. More importantly, the program has been found to be effective even to those with difficulties in weight management, blood pressure, depression, and diabetes among other conditions. It is about natural solutions that attack your problem from the core. By means of simple booster tricks unleashed in the guide, your body will be rejuvenated to prevent the disease along with harmful bacteria from getting into your body. In case the product does not serve you as expected, feel free to claim for a refund. There is a 60-day money back guarantee and unlike other products, you will still maintain ownership of the course along with all the bonuses.

Prescription Freedom Natural Remedies To Live Drug Free Summary


4.6 stars out of 11 votes

Contents: Ebook
Author: Kevin Christianson
Price: $47.00

My Prescription Freedom Natural Remedies To Live Drug Free Review

Highly Recommended

I started using this book straight away after buying it. This is a guide like no other; it is friendly, direct and full of proven practical tips to develop your skills.

When compared to other ebooks and paper publications I have read, I consider this to be the bible for this topic. Get this and you will never regret the decision.

Download Now

For computerissued prescriptions the following advice

When prescriptions are to be signed by general practitioner registrars, assistants, locums, or deputising doctors, the name of the doctor printed at the bottom of the form must still be that of the responsible principal. 5. The dictionary may contain information on the usual doses, formulations, and pack sizes to produce standard predetermined prescriptions for common preparations, and to provide a check on the validity of an individual prescription on entry. 13. Handwritten alterations should only be made in exceptional circumstances it is preferable to print out a new prescription. Any alterations must be made in the doctor's own handwriting and countersigned computer records should be updated to fully reflect any alteration. Prescriptions for drugs used for contraceptive purposes (but which are not promoted as contraceptives) may need to be marked in handwriting with the symbol , (or endorsed in another way to indicate that the item is prescribed for contraceptive purposes). 14....

Notification of drug misusers

Doctors should report cases of drug misuse to their regional or national drug misuse database or centre see below for contact telephone numbers. The National Drugs Treatment Monitoring System (NDTMS) was introduced in England in April 2001 regional (NDTMS) centres replace the Regional Drug Misuse Databases. A similar system has been introduced in Wales. Notification to regional (NDTMS) or national centre should be made when a patient starts treatment for drug misuse. All types of problem drug misuse should be reported including opioid, benzodiazepine, and CNS stimulant. The regional (NDTMS) or national centres are now the only national and local source of epidemiological data on people presenting with problem drug misuse they provide valuable information to those working with drug misusers and those planning services for them. The databases cannot, however be used as a check on multiple prescribing for drug addicts because the data are anonymised. Public Health Information & Research...

Prescription Drug Advertising

The benefits of direct-to-consumer (DTC) advertising of drugs, including internet advertising, are controversial. DTC advertising has alerted consumers to the existence of new drugs and the conditions they treat but has also increased consumer demand for drugs. This demand has increased the number of prescriptions being dispensed (raising sales revenues), which has led to higher pharmaceutical costs borne by health insurers, government, and consumers. In the face of a growing demand for particular brand name drugs driven by advertising, physicians and pharmacists must be able to counsel patients effectively and provide evidence-based drug information to their patients.

Common Comprehensions on Prescription Drug Abuse

Small Pupils Drugs

The street value of a prescription drug is dependent on whether it is a brand or generic. Even abusers know that they get what they pay for when buying a brandname drug. Drugs that have a quick onset - immediate-release or injectable drugs -are more sought after, as well as those that have a greater intensity. The demand for drugs with a short duration of action is consistent with the rate hypothesis of reinforcement - the faster the drug enters the system, the quicker it causes the dopamine surge in the nucleus accumbens, which is associated with euphoria. Street value also depends on whether the product can be injected or snorted successfully. Prescription drug abuse occurs because the controlled substances that work effectively for patients with legitimate need are commonly prescribed. As controlled substances are prescribed more often, their availability increases. As a result, opportunities for diversion increase because more people have access to the drug for abuse or diversion,...

Prescription Drugs

The concern for prescription drug abuse has recently overshadowed that of illicit drug abuse, as the non-medical use of scheduled medications prescribed for pain, pain-related symptoms, and psychiatric disorders began rising in the mid-1990s. Non-medical use of prescription drugs was previously estimated in about 0.7 million individuals, 0.5 million of which used prescription pain relievers such as codeine, meperidine, morphine, fentanyl, hydro-morphone, hydrocodone, methadone, and oxycodone (Joranson et al. 2000). In 2003, the lifetime prevalence rates for non-medical use of opioids increased to about 3 million (Smith and Woody 2005). While opioid drug mentions decreased by 25 from 1990 to 1996, year 2000 and 2003 updates showed a significant increase in oxycodone mentions (Joranson et al. 2000, Office of Applied Studies, Substance Abuse and Mental Health Services Administration 2003). The prevalence of opioid abuse is now similar to that of cocaine and only second to that of...

Applications to the Synthesis of Commercial Drug Molecules

A number of syntheses targeting commercially available drugs have been reported, which demonstrate the utility and effectiveness of supported reagents for the rapid and efficient preparation of drug-like scaffolds. The introduction of Sildenafil45 4 for the treatment of male erectile dysfunction has been incredibly successful, resulting in it becoming one of the largest selling globally marketed prescription drugs.46 Sildenafil acts by inhibiting the phosphodiesterase enzyme PDE5, which is the main phosphodiesterase present in the smooth muscle of the corpus cavernosum. Upon sexual stimulus, nitric oxide is released from nerve terminals in the corpus cavernosum. The nitric oxide activates guanylate cyclase to produce cyclic guanosine monophosphate (cGMP), causing the intracellular levels of cGMP within the smooth muscle cells of the penis to increase. In healthy tissue, the elevated cGMP is returned to basal levels by the action of the PDE5 enzyme. Inhibition of the PDE5 enzyme...

Approved Name Nonproprietary A

Prescription-only medicines A1 , This symbol has been placed against those preparations that are available only on a prescription issued by an appropriate practitioner. For more detailed information see Medicines, Ethics and Practice, No. 34, London, Pharmaceutical Press, 2010 (and subsequent editions as available). The symbol id indicates that the preparation is subject to the prescription requirements of the Misuse of Drugs Act. For regulations governing prescriptions for such preparations see p. 8. Prices have been calculated from the basic cost used in pricing NHS prescriptions, see also Prices in the BNF, p. xiv for details.

The Health of Our Nation

Americans have private health insurance, health costs have risen dramatically and the insurance industry has increasingly shifted health care costs onto the consumer, mostly through out-of-pocket expenses. Between 1997 and 2002, consumer out-of-pocket health care expenses increased from 17 to 20 percent. Prescription drug costs represented about 23 percent of total out-of-pocket expenses for those aged 55 to 64. Added to increasing health care costs is the burden of the uninsured. In 2003, 17 percent of Americans under the age of 65 years, in a minority group, or with incomes below or at poverty level were uninsured.14 A recent Health and Wellness Trend Report by the National Marketing Institute (NMI) found consumers associate antioxidant supplements with cancer prevention (32 ), immune function (23 ), and heart health (17 ). Adults with medical conditions were more likely to take a dietary supplement. Nearly 81 percent of breast cancer survivors, with a high risk for recurrence,...

Emergency supply requested by member of the public

Pharmacists are sometimes called upon by members of the public to make an emergency supply of medicines. The Prescription Only Medicines (Human Use) Order 1997 allows exemptions from the Prescription Only requirements for emergency supply to be made by a person lawfully conducting a retail pharmacy business provided (a) that the pharmacist has interviewed the person requesting the prescription-only medicine and is satisfied (i) that there is immediate need for the prescription-only medicine and that it is impracticable in the circumstances to obtain a prescription without undue delay (ii) that treatment with the prescription-only medicine has on a previous occasion been prescribed for the person requesting it (b) that no greater quantity shall be supplied than will provide 5 days' treatment of phenobarbital, phenobarbital sodium, or Controlled Drugs in Schedules 4 or 5,1 or 30 days' treatment for other prescription-only medicines, except when the prescription-only medicine is (e) that...

Emergency supply requested by prescriber

Emergency supply of a prescription-only medicine may also be made at the request of a doctor, a dentist, a supplementary prescriber, a community practitioner nurse prescriber, a nurse, pharmacist, or optometrist independent prescriber, or a doctor or dentist from the European Economic Area or Switzerland, provided

Reasons For Insufficient Opioid Use The 11 Myths In Opioid Therapy

Such consideration appears to be more and more necessary, since governmental regulations have not eased the legal prescription of opioids. Enforcement agencies and regulatory legislature in the past years have impeded their early use 93 . And although prescription of opioids such as morphine in the western world is characterized by a steady increase (Figure I-49), there is still prejudice when it comes to the use of opioids for treatment of chronic pain. The following arguments often are stated as an explanation to refrain from regular opioid use or writing out prescriptions

The Pain Patient With A Suspected Substance Abuse Problem

Stances, alcohol, or prescription drugs.43 Pain patients who are perceived to have addictive disorders are often undertreated. The unwarranted fear of addiction is a misunderstood concept in pain management that can lead to the undertreatment of pain. The increasingly accepted management of chronic nonmalignant pain with opioid therapy underscores the importance of understanding the nature of opioid addiction. As important as the psychological assessment of the chronic pain patient is in gen

Pharmacogenetics Moving From Research To The Clinic

With a few exceptions, the current level of knowledge of efficacy pharmacogenetics in psychiatry is still in the exploratory stage, with as yet no robust results for genes predicting efficacy. However, some findings are replicating in independent sample sets and promising leads are developing, for example the serotonin gene promoter gene and SSRI response, dopamine D3 receptor gene and risk of anti-psychotic induced tardive dyskinesia. Many of these are presented within the following chapters of this book. Understanding of the impact of allelic variance on pharmacokinetic parameters can perhaps be considered to represent our current, most advanced state of pharmacogenetic knowledge. An example of this was recently seen in the approval of atomoxetine (Strattera Eli Lilly), approved by the FDA in November 2002 for attention-defeceit hyperreactive disorder. This drug is metabolised by CYP2D6 with the ratio (PM EM) for an area under the curve (AUC) of 10. Lilly conducted a post-facto...

Surveys Of Pain In The Community

40 percent reported they were less able to walk, 56 percent less able to sleep, and 21 percent were diagnosed with depression. Most respondents were seeking treatment for pain (69 percent) and taking prescription medications (52 percent). A few additional findings not included in Figure 13.1 were that 32 percent of respondents considered themselves no longer able to work outside the home and around 50 percent considered themselves less able to do lifting or exercising. Mean time lost from work in the

Dietary Supplement Regulations

Regulation of dietary supplements has had a long and sometimes controversial history. Most Americans assume dietary supplements are as tightly regulated as OTC and prescription medications are. But with the passage of the Dietary Supplement Health and Education Act of 1994 (DSHEA), dietary supplement controls were relaxed. Supplement manufacturers are no longer required to provide data supporting safety as required for both OTC and prescription drugs. In order to understand the evolution of current regulations, it is insightful to explore the history of food and drug regulations. Prior to 1994 the FDA maintained tight control over premarket approval of all drugs and foods, including dietary supplements. But in 1976, after years of debate, Congress passed the Proxmire bill that prohibited the FDA from regulating vitamins and minerals as prescription drugs. This eventually led to the passage of DSHEA in 1994, which effectively ended tight FDA control over dietary supplements. The...

Side effects and their management

Overall, NSAIDs have a good safety record but, due to the enormous quantities prescribed, they account for a large proportion of serious adverse drug events. In 1985, from all reported adverse drug reactions, NSAIDs accounted for 25 percent in men and 30 percent in women. The elderly account for approximately 40 percent of NSAID prescriptions and are at greater risk of side effects.19 In a recent retrospective study conducted by Gallelli et al.,20 NSAIDs were found to be responsible for 55.2 percent of the episodes of adverse drug reactions overall. Diclofenac and aspirin were the drugs most frequently involved, while the skin was the system most susceptible to NSAID-induced adverse drug reactions (43 percent). Withdrawal of NSAID therapy resulted in resolution of side effects in 86 percent of episodes. NSAID side effects may present with a life-threatening event. As well as the elderly, those at higher risk include patients who are hypovolemic, immunocompromised or taking...

WHO guidelines for herbal medicines

WHO has also issued Guidelines for the Assessment of Herbal Medicines (WHO, 1996). These guidelines defined the basic criteria for the evaluation of quality, safety and efficacy of herbal medicines with the goal of assisting national regulatory authorities, scientific organizations and manufacturers in assessing documentation, submissions and dossiers in respect of such products. It was recommended that such assessments take into account long-term use in the country (over at least several decades), any description in the medical and pharmaceutical literature or similar sources or documentation of knowledge on the application of a herbal medicine, and marketing authorizations for similar products. Although prolonged and apparently uneventful use of a substance usually offers testimony of its safety, investigation of the potential toxicity of naturally occurring substances may reveal previously unsuspected problems. It was also recommended that regulatory authorities have the authority...

Natural Products of Non Botanical Origin

Vertebrate tissue extracts have also been used as medicines for thousands of years. In fact, many prescriptions containing animal products are listed in Egyptian papyrus. In recent years, the pharmacology of various extracts, particularly of endocrine organs, has been investigated. Extracts from pituitary, thyroid and adrenal glands have been shown to exhibit dramatic effects when administered to vertebrates, and the active principles of these extracts have been isolated. The chemistry and biological activity of many important endogenous constituents of endocrine organs, such as epinephrine, thyroxine, corticosterone, insulin, prostaglandins, leukotrienes, endorphins, atrial natriuretic factor, nitric oxide, and endothelin have been elucidated, and information obtained from these studies has been used as a basis for the development of many clinically useful drugs.

Summary Of Dossier Preparation And Experience Of Getting It Through Regulatory Agencies

The regulation of Filgrastim, as a biological response modifier, is governed by different laws than those for traditional pharmaceutical drugs. In the United States, drugs are covered under the Food, Drug and Cosmetic Act (FD&C), and biological response modifiers have additional laws under the Public Health Services Act (PHS). The approval requirements for a drug include more than one adequate and well-controlled study demonstrating both safety and efficacy. Approval requirements for Filgrastim also included an adequate and well-controlled study as well as supporting studies.

Substance Related Disorders

One feature of substance dependence suggestive of a pathologic state is the desire for acquisition of such substances (e.g., opiates) for something other than just pain relief (i.e., for psychological relief). Behaviors suggestive of substance abuse or dependence include problematic behaviors such as solicitation of medications from multiple sources, forgery of prescriptions, theft of medications, and acquisition of psychoactive substances from illegal sources.

Substance Abuse and Dependence

Of particular concern is the relationship of opioid dependence to chronic pain. It is arguable that signs of physiological dependence, i.e., demonstration of tolerance to the effects of opioids or the precipitation of withdrawal with abrupt medication cessation, would naturally result from the chronic administration of opioid analgesics and otherwise do not signal psychological dependence that accompanies dependence or addiction. Instead, psychological signs of dependence would be reflective in behaviors suggesting a loss of control over the use of opioids, e.g., using more of the opioid than intended using the agent to acquire effects apart from analgesia, e.g., emotional effects going to inordinate lengths to acquire, use, or recover from the opioids and using the agent to the point of, and despite, inducing deleterious effects. Behaviors suggestive of loss of control, and therefore dependence, include lying, seeking additional prescriptions from other doctors, using street drugs,...

Labeling of Biologically Active Molecules

In recent years, the labeling of biologically active molecules has become the most effective tool to generate affinity of a Tc-99m complex for a specific biological target. The most common design of this type of diagnostic agent is based on the application of two main methods called bifunctional (or pendant) and integrated approaches 38 . The first step in both strategies always requires the selection of a convenient biologically active molecule or a pharmaceutical drug having affinity for a definite biological substrate. After this common onset, the two methods follow separate routes. The bifunctional approach literally suggests putting together the bioactive group and the metal complex through a suitable linkage, a result that can be conveniently achieved using a bifunc-tional ligand. This species could be represented as a composite molecule combining two different molecular blocks such as a strong chelating group for the metal and a biomolecule. Thus, in the final ligand, these two...

Biomedical Potential of These Toxins

A previous examination of the saxitoxins as drug candidates using the Lipinski rule of five (Lipinski et al. 1997) highlighted the fact that the high number of violations of this rule would severely hinder their progression as oral drug candidates in most pharmaceutical drug discovery programs (Llewellyn 2006). The rule of five is a series of simple chemical descriptors common to over 90 of orally available drugs successfully developed by the pharmaceutical industry. Yet, the saxi-toxins as well as the tetrodotoxins are highly effective orally available chemicals their systemic uptake from toxic shellfish or pufferfish meals being rapid with signs of poisoning occurring within minutes of ingestion and death may occur within hours. More recently, a detailed chemoinformatic study (Llewellyn 2007) identified a group of chemical descriptors that when combined with multivariate statistics could be used to predict the known toxicity of saxitoxins (Fig. 7). Chemical descriptors

Genetic and related effects

Detection of AA-specific DNA adducts in the kidneys of CHN patients (37 female and one male), and in 17 ureters from 11 of these patients from Belgium by 32P-postlabelling. Among these patients were 18 cases of urothelial carcinoma. Data were related to cumulative doses of compounds in the weight-reducing pills on the basis of all prescriptions made during the period of exposure (1990-92). The cumulative dose of aristolochia was a significant risk factor for developing urothelial carcinoma. The kidneys and ureters from the CHN patients had the same pattern of adducts consisting of dA-AAI, dG-AAI and dA-AAII. The major adduct dA-AAI was detectable up to 89 months after discontinuation of use of the weight-reducing pills. No statistically significant difference was observed between mean levels of dA-AAI DNA adducts determined in renal tissue samples from patients who had developed urothelial carcinoma and those from tumour-free patients. Detection of AA-specific DNA adducts in the...

Brief history of acupuncture

During the fourth to the tenth centuries, acupuncture became ingrained in Chinese medicine and was officially recognized as an independent specialty of the Imperial Medical Academy of the Tang government in 618AD. During this same period, acupuncture, together with other branches of Chinese medicine, was introduced to other countries such as Japan.28 During the eleventh to the early twentieth century, volumes of written material came out on acupuncture prescriptions. Acupuncture

Biochemistry And Toxicity 151 Biological Persistence

Among the proteins induced by the Ah receptor are three cytochrome P450 enzymes CYPIA1, CYPIA2, and CYPIB1. These phase I enzymes oxidize foreign (xenobiotic) substances, including PAHs, plant constituents such as flavones, aromatic amines, and some pharmaceutical drugs. One consequence of this metabolic conversion is that the xenobiotic substance, typically lipid- rather than water-soluble, is then subject to further enzymatic conversion. Phase II enzymes add hydrophilic groups, enhancing water solubility and excretion from the body. In this manner, AhR-induced enzymes can reduce the biological effect of some environmental agents by facilitating their metabolic

Continuous Production of a Key Intermediate for Atorvastatin

Since 2000, atorvastatin (1) has been the world's top selling prescription drug, with sales in the 12 months to June 2008 of 13.8 billion 4 . The conversion of the chloro alcohol 2 to the key atorvastatin intermediate hydroxy nitrile 3 (Scheme 11.1) provides a good case history for the development of a continuous process, as it demonstrates

Constraints and context

One of the most dramatic recent achievements in using phage display of peptide libraries to develop lead molecules for pharmaceutical drugs was the isolation of an agonist for the erythropoietin receptor (EPOR Refs. 33 and 112), which normally mediates erythropoiesis in response to erythropoietin (EPO Kd for the receptor 200 pM). EPO has become a standard therapeutic for the treatment of various anaemic conditions. Soluble EPOR was available for use as an immobilized target. A type 8+8 library (3 x 109 primary clones) of constrained (cyclic) random octamers, i.e. bracketted by cysteines, was used initially. The idea in using such a library was that, by using a multivalent presentation, motifs might be obtained, which, even if exhibiting low affinity, would indicate the direction to take in developing further analogues. Initial experiments using acid elution were unsuccessful. Positive results were obtained first by using a thrombin cleavable site between the ligand and pVIII, which...

Nonpharmacologic Options

Treating fibromyalgia requires a combination of therapeutic options in addition to pharmacologic prescriptions. It is not a condition than lends itself to monotherapy. Using a combination of medications with integrative medicine techniques typically yields the best outcomes and provides the biggest benefit to the patient. The APS Fibromyalgia Guidelines (2005) recommend the addition of one or more of the following therapies

Summary and future trends

Many of the studies with phage display are directed towards the development of pharmaceuticals. Peptides and proteins are generally not favoured, because of their poor phar-macokinetic properties, immunogenicity and, for larger proteins, their poor penetration into tissue. On the other hand, the concept of a 'lead molecule' is prevalent in the development of small synthetic pharmaceutical drugs. This requires that three-dimensional structural predictions can be made for the isolated ligands, so that a synthetic chemist may initiate a project to make a mimotope, hopefully having these desirable characteristics 208 . Free peptides and larger proteins, such as antibodies, with flexible complex interactions cannot easily be modelled. This explains to some extent the tendency to produce small compact matrices, such as tendamistat, protein A (mini Z-domain), BPTI, PSTI, PAI, ecotin, ANP-minido-main and CP-1 (Table 2) to present constrained epitopes, as well as the use of constrained...

Genetic Polymorphisms Predicting Drug Response

In addition to polymorphisms in the genes encoding drug-metabolizing enzymes, genetic variants in the genes involved in the therapeutic pathway or promoters of these genes may influence clinical response to treatment. Therefore, genetic biomarkers may facilitate classification of individuals by level of response, improving therapeutic outcome and allowing for personalized prescriptions. Although the widespread clinical utility of such genetic biomarkers is yet to be

Off Label Use of Drugs

The label is a document about a drug, which is approved by governmental regulatory agencies, such as the Food and Drug Administration (FDA) in the US and the European Medicines Agency (EMEA) in the EU. The label is the source for the package insert. The label includes the drug's approved indications, that is, the conditions, diseases, disorders, that can be treated with the drug. Offlabel use refers to the practice of using a drug for the treatment of a disease or condition that is not listed on its label, or used in such a way that is not described in the label (e.g., in higher doses). Synonyms of off-label are extra-label use, nonapproved use or unapproved use. Offlabel prescription raises legal and ethical issues. Some countries ban or restrict off-label use of drugs. Insurance companies may reject the reimbursement claims for offlabel prescriptions. In case of unexpected side effects adverse events of the drug treatment (unexpected adverse events are those, which are not described...

Compounding Records And Documents

All compounders who dispense prescriptions must comply with the record keeping requirements of their individual states. If the compounder compounds a preparation according to the manufacturer's labeling instructions, then further documentation is not required. All other compounded preparations require further documentation. Such compounding documents are to list the ingredients and the quantity of each in the order of the compounding process.

Special Considerations

In the United States, smokers and passive smokers, men (particularly the elderly), those in lower socioeconomic classes, those with poor fruit and vegetable intake, drug and alcohol abusers, and those with chronic diseases and disabilities (particularly hemochromatosis and renal disease) are at a higher risk for low blood levels of vitamin C. Some pharmaceutical drugs birth control pills and aspirin (when taken frequently) are known to lower vitamin C levels in the body as well. There is some evidence that vitamin C can interact with anticoagulant medications (such as coumadin) and high doses have been found to affect lab test results. Therefore, it is extremely important for patients to report vitamin C supplement use to their health care providers and to discontinue use of vitamin C dietary supplements at least two weeks prior to any planned blood or urine testing.

Managing Pain in the Addicted Patient

Approximately 20 million Americans have some form of substance abuse disorder, and about one-third of the US population has used illicit drugs (Substance Abuse and Mental Health Services Administration office of Applied Studies 2007). Substance abuse is known to occur in 10-16 of outpatients in general medical practice, 25-40 of hospital admissions, and 40-60 of major trauma patients (Manchikanti et al. 2003, Rosenblatt and Mekhail 2005). In chronic pain management settings, illicit drug use has been reported in 14-34 of patients (Manchikanti et al. 2006). Among the illicit drugs, use of marijuana is reported most common, followed by that of cocaine, hallucinogens, and methamphetamines. Such high prevalence of illicit use, along with concerns of drug abuse and addiction, and its association with life-threatening pathophysiological effects, often has a negative influence on pain treatment. Pain patients who have current or remote histories of drug abuse present a multitude of medical...

Avoiding Abuse Liability When Prescribing Opioids

To determine if the patient is consistently using one pharmacy. Also count any remaining medication to determine use patterns 2 . It is necessary to monitor for lost or stolen prescriptions. The patient should be responsible for prescriptions. One approach is to give the patient a refill on the first lost prescription. The patient is then informed that further lost or stolen prescriptions will result in periods without medication. Although a lesser problem, however, it was observed that physicians who contribute to the problem of prescription drug abuse have been described by the American Medical Association as dishonest-willfully misprescribing for purposes of abuse, usually for profit disabled by personal problems with drugs or alcohol dated in their knowledge of current pharmacology or therapeutics or duped by various patient-initiated fraudulent approaches. Even physicians who do not meet any of these 4D descriptions (dishonest prescription, disabled personal problems, dated in...

Prescribing Opioids The Controlled Substances Act from 1979

Title 21 Code of Federal Regulations (CFR), part 1306.05, paragraph (a) is the citation style used for federal regulations. This citation says that all prescriptions for controlled substances shall be dated as of, and signed on, the date when issued and shall bear the full name and address of the patient and the name, address, and registration number of the practitioner. The key element here is that post-dating a prescription cannot be in compliance with federal law, and state law echoes this. It should be remembered, state law can be more restrictive than or equally restrictive to federal law, but it cannot be more lax. What do you do if you want to give a patient more than one month's supply of a Schedule II medication, which is not refillable, but his or her insurance company will only pay for one month at a time Write two prescriptions today, date them today, sign them today, and put a note to the pharmacist on one of them - please do not fill before - and put in the date a month...

Opiate Adulteration and Misuse

Concerted efforts on the part of clinicians in screening patients for problematic prescription and illicit substance use (e.g., Prescription Drug Use Questionnaire) (Compton et al. 1998) may help to avoid contributing to analgesic misuse and adulteration. In addition, ongoing efforts on the part of the pharmaceutical industry will be necessary to refine strategies that reduce opportunities for adulteration and misuse.

Economic Considerations

Since the evolution of DRG's in the 1970's and more recently health care reform of the 1990's, the consideration of product economic impact on health care costs has been paramount. In the case of higher market priced prescription medications and biotechnological genetic products, it is critical to demonstrate cost effective viability to gain market acceptance. Of course, these mechanisms are best considered during the early stages of clinical validation versus late stage pre marketing.

Legal Issues Related to Opioid Prescribing

Pharmacists, likewise, are responsible to ensure that the prescriptions are legitimate, to determine the purpose of the medication, and to verify that the person to whom the medication is dispensed is the intended recipient. If another is acting on behalf of the patient, it may be prudent to ensure that the individual is indeed acting as the patient's representative and to secure government issued photo identification (included in the patient's record). Such measures may mitigate concerns regarding lost or stolen prescriptions.

Table 101 Items to be factored into a patient contract for use with controlled substances

Specify that prescriptions for controlled substances will be made only during regular office hours not at night, on weekends, on holidays, and so forth. Be present in person to pick up prescriptions for controlled substances. and acquisition of analgesics and other treatment responsibilities. The patient is made aware of his or her responsibilities with regard to use of the medication other responsibilities regarding participation in nonpharmacologic facets of treatment (e.g., physical therapy, smoking cessation, avoidance of alcohol, weight loss, psychotherapy, substance abuse treatment) can also be delineated. The patient is informed that violation of the conditions of the contract can allow the physician to terminate the use of controlled substances. The contract can specify limitations regarding the acquisition of controlled substances (e.g., that prescriptions will not be provided for running out early, prescription loss, or spilled or misplaced medications) and can state that...

Proper Patient Information

Prescribers often commit errors in dosage calculations that can be prevented. When prescribing a drug whose dosage involves a calculation based on body weight or surface area, it is good practice to include both the calculated dose and the dosage formula used, such as 240 mg every 8 hours (40 mg kg per day) to allow another health care professional to double-check the prescribed dosage. Pharmacists always should recalculate dosage equations when filling these prescriptions. In hospitals and some clinic settings, medication orders for antibiotics or antiseizure medications that are sometimes difficult to adequately dose (e.g., phenytoin) can specify the patient diagnosis and desired drug and request dosing by the clinical pharmacist. All prescriptions should be written in ink this practice is compulsory for schedule II prescriptions under the Controlled Substances Act of 1970, as erasures on a prescription easily can lead to dispensing errors or diversion of controlled substances....

Electronic Prescription Writing

Both government and healthcare businesses have called for the widespread use of electronic medical records by 2014 to help lower costs, reduce medical errors, improve quality of care, and provide better information for patients and providers. Electronic prescriptions are a central part of this strategy while no national standard for either the technology or format of this record exists, electronic prescriptions are being used in many parts of the country. The advantages of electronic prescription writing include convenience for the prescriber (e.g., use of hand-held devices permits prescribing at the time of therapeutic decision making) convenience for the patient, and electronic screening for appropriate drug choices, interactions with existing therapy, etc. The high probability that electronic prescription writing will reduce medication errors is, in and of itself, justification to make the change from current practice. Whatever the specific format of the electronic prescription,...

Controlled Substances

DEA regulates each step of the handling of controlled substances from manufacture to dispensing. State agencies may impose additional regulations such as requiring that prescriptions for controlled substances be printed on triplicate or state-issued prescription pads or restricting the use of a particular class of drugs for specific indications. The most stringent law always takes precedence, whether it is federal, state, or local. Substances that come under the jurisdiction of the Federal Controlled

Execution of the Order

Prescriptions for controlled substances should be dated and signed on the day of their issuance and must bear the full name and address of the patient and the printed name, address, and DEA number of the practitioner they should be signed as one would sign a legal document. Preprinted orders are not allowed in most states, and presigned blanks are prohibited by federal law. When oral orders are not permitted (schedule II), the prescription must be written with ink or typewritten. The order may be prepared by a member of the physician's staff, but the prescriber is responsible for the signature and any errors that the order may contain.

Summary of Considerations When Having a Positive Urine Test

Therapeutic uses for amphetamine and methamphetamine include attention deficit disorder, treatment of exogenous obesity, and treatment of narcolepsy and CNS disorders 59 . Examples of prescription medications that contain amphetamine or methamphetamine are Adderall , Benzedrine , Dexedrine , and Desoxyn . In the case of adherence testing, a negative result may lead to concerns about misuse (e.g., escalating dose of an opioid leading to running out of the analgesic, bingeing of prescription medication, diversion of the agent) 62 . The most appropriate use of a negative result for a prescribed medication is to initiate a dialog with the patient in order to clarify the result and to preserve the therapeutic alliance.

Is The Opioid Prescription Being Used By The Intended Recipient

Selling prescription drugs Aggressive complaining about the need for more drug Obtaining prescription drugs from nonmedical sources Unsanctioned dose escalation transfer of prescription drugs from intended recipient to others in pain unlawful transfer of prescription drugs from legitimate to illegal channels of distribution use of over-the-counter or prescription medicines to synthesize more potent drugs with a higher street value

Hair Analysis for the Detection of Abused Drugs and Medications

To summarize, one orders a UDT, takes a detailed history of the medications a patient uses, including prescribed, over-the-counter (OTC), and herbal drugs, with dose and time of last use, and his or her drug misuse addiction history. And let the laboratory know what you are looking for i.e., an illicit substance, prescription drug misuse, or presence of a prescribed medication.

Drug Delivery System and Compliance Issues

Hundreds of excipients have been approved by FDA for use as inactive ingredients in drug products. The FDA Division of Drug Information Resources compiles a list of all inactive ingredients in approved prescription drug products in the Inactive Ingredient Guide (available at The FDA requires the listing of excipients in pharmaceuticals other than oral. The labeling of inactive ingredients in oral drug products is voluntary. The reported incidence of adverse drug reactions to excipients is much lower than the incidence reported with active drug. This may be due to several factors, including the generally safe nature of the excipients, the low concentration found in single doses, or lack of identification of an excipient as a causative agent.

Adrenergic Drugs Preface

This book provides, in the first place, useful scientific background to those involved in pre-clinical research and to those who need to function within multi-disciplinary teams in the pharmaceutical industry (from medical chemistry and molecular biology via pharmacology to drug marketing). Today's education of researchers in the pharmaceutical industry needs to be broad and insight into pharmacological issues needs to be warranted. In this respect, the focus on G protein-coupled receptors (GPCRs) is rationalised by the fact that they constitute major cellular targets for pharmaceutical drugs. The aim is also to provide students and investigators with a basic interest in life sciences an insight into the fast evolving GPCR field. More generally speaking, to create knowledge in the domain of molecular pharmacology. In this respect, the book will also provide necessary background for the elaboration and reading of research papers on GPCRs and even information brochures about...

Caffeine and benzodiazepines

Benzodiazepines are widely used for the treatment of anxiety and insomnia as well as a variety of other disorders. In most countries they are available on medical prescription. Problems of dependence and abuse have been recognized for some time, although the dependence potential of these drugs remains a matter of contention.14 In addition to their anxiolytic and hypnotic effects, benzodiazepines produce sedation, muscle relaxation, and cognitive and psychomotor impairment.

Limitations Faced In Preclinical Safety Assessment

A critical problem faced by nonclinical safety assessment groups in pharmaceutical drug development is the disparity of responses sometimes seen between the two nonclinical test species in the tools used to assess these responses. Historically, microscopic histopathology is used as a primary tool for identifying compound--nduced damage. When damage is identified only at exposures far exceeding those expected in clinical studies, clinical safety is expected. However, microscopic histopathology is not a tool generally applicable to human studies, where clinical pathology measurements play the criti

Clinical pharmacology Filgrastim and

Role in therapy According to the manufacturer, until now, filgrastim was the only prescription drug shown to decrease risk of infection and hospitalization as a result of chemotherapy-induced neutro-penia. The burden of daily dosing (up to 14 consecutive days), however, led many physicians to delay intervention until a patient developed a neutropenic infection.

Angiotensin AT1 Receptor a GProtein Coupled Receptor

At1 Receptor

Hypertension is the most prevalent disease in developed countries, with approximately one billion cases worldwide 2 . Various classes of antihypertensive agents have been introduced into therapy over the last 30-40 years. Yet hypertension remains an under-treated disease and a major health problem worldwide. Valsartan has become an outstanding representative of the angiotensin II type 1 (ATI) receptor antagonists, which are highly effective at reducing blood pressure and at the same time exhibit both renoprotective properties and placebo-like tolerability 3 . They, thus, provided a considerable advance over the earlier angiotensin converting enzyme inhibitors, which inhibited angiotensin II formation, but resulted in coughing due to the concomitant formation of the peptide mediator, bradykinin. The biological target of the newer antihypertensive drugs is the angio-tensin ATI receptor (see Fig 2.1, Chap. 2) that belongs to the largest human gene superfamily, the G-protein-coupled...

Ephedra Ma Huang And Related Drugs

Ma huang (ephedra) is commonly found in herbal weight loss products that are often referred to herbal fen-phen. Some weight loss clinics and herbal outlets promote 'Herbal fen-phen' as an alternative to fenfluramine, the prescription drug that has been withdrawn from the market due to toxicity. Herbal fen-phen products sometimes contain St John's wort and are sold as 'herbal prozac'. Ephedra-containing products are also marketed as decongestants, bronchodilators and stimulants. Other promoted uses include bodybuilding and enhancement

The Fenphen Story Serotonergic Mechanisms Determine Drug Induced Valvular Heart Disease

Appetite suppressant medications have been used worldwide for decades for the treatment of obesity. One of the most widely prescribed anorectic agents was fenfluramine either alone or in combination with the noradrenergic drug phen-termine (''fen-phen''). When used in combination, the drugs may be just as effective as either drug alone, with the added advantage of the need for lower doses of each agent and perhaps fewer side effects. Each drug received FDA approval individually in 1996, but the combination was not approved. In that year, the total number of prescriptions in the United States for fenfluramine and phentermine exceeded 18 million.

Overview of the Glutamatergic System

The complexity of regulating glutamate and its pervasive presence throughout the brain may explain why, over the past decades, only three prescription medications have been developed that specifically target glutamate or glutamate receptors, memantine, ketamine, and D-cylcoserine. The potential for side effects from these medications is extremely high, which

Assay Types For Gpcrs IN uHTS 1321 Radioligand Displacement Assays

The radioligand displacement assay was one of the earliest assays used to study GPCRs. For nearly 50 years, the radioligand displacement assays, also known as competition binding assays, were used by the pharmaceutical industry as a preferred screening method to identify candidate drug molecules capable of binding to GPCRs, the largest group of pharmaceutical drug targets involved in a variety of physiological disorders.

Fear of regulatory scrutiny of opioidprescribing practices

Despite the pervasive view among healthcare professionals in the United States that the policies and practices of the DEA have had a chilling effect on the willingness of professionals to prescribe opioid analgesics for their patients even when clinically indicated, the DEA remains in denial, going so far as to post on its website in October of 2003 a press release entitled The Myth of the Chilling Effect.'' The thrust of the statement was that doctors operating within the bounds of accepted medical practice have nothing to fear from the DEA.''41 The purported justification for the have no fear'' message was that only a small percentage (less than 0.10) of all physicians registered by the DEA were investigated or prosecuted in 2003. What the DEA, and other governmental agencies with jurisdiction over prescription drugs fail to recognize is that perception is reality,'' for healthcare professionals, as well as the lay public. A recently published report on the use of opioids in Europe...

Pharmacology and Toxicology

Currently the FDA approves drugs based on a risk-benefit assessment the agency considers that no prescription drug is free of risk. All prescription drugs carry some risks, and heath care professionals with prescriptive authority (physicians, nurses, and pharmacists) are the risk managers. Therefore health care professionals must have a clear understanding of the pharmacology and toxicology of biopharmaceuticals.

Drug Addiction And Drug Abuse Drug Dependence

Although many physicians are concerned about creating addicts, relatively few individuals begin their drug addiction problems by misuse of prescription drugs. Confusion exists because the correct use of prescribed medications for pain, anxiety, and even hypertension commonly produces tolerance and physical dependence. These are normal physiological adaptations to repeated use of drugs from many different categories. Tolerance and physical dependence are explained in more detail later, but it must be emphasized that they do not imply abuse or addiction. This distinction is important because patients with pain sometimes are deprived of adequate opioid medication simply because they have shown evidence of tolerance or they exhibit withdrawal symptoms if the analgesic medication is stopped abruptly.

Spinal cord stimulation

Cost-effectiveness of spinal cord stimulation has been evaluated in several healthcare economies. Taking into consideration the reduction in hospital admissions, as well as the reduction in prescriptions, it is thought to be cost- effective.38 The expense of the procedure and the device was recovered within 16 months of insertion. However, these conclusions were based on retrospective

Introduction of traditional herbal medicines into Europe the USA and other developed countries

One of the most difficult issues to contend with in translating traditional herbal practices into conventional 'western' medicine is the individualization of prescriptions containing multiple herbal and other ingredients. There is little incentive for standardization of products for a mass market, when the intention has been to provide an individual prescription. To the small grower or the traditionally trained herbalist, standardization means understanding the growth conditions, the time of harvesting, the manner of extraction or other preparation of material so that a reliable (albeit small amount of) active ingredient can be offered to people. To the manufacturer or distributor of large quantities that will be sold in a supermarket or a health food store, standardization refers to industrial production under defined conditions, using so-called Good Manufacturing Practices (GMP) (Food & Drug Administration, 2002) akin to those used for drug production. Safety of some herbal...

Abuse Liability

Abuse liability is a term used to denote properties of a drug that would lead to abuse and dependence in humans if it were to become available as a prescription medication or through illicit routes. It is assessed primarily from the ability of a drug to produce positive outcomes in laboratory tests predictive of abuse and dependence in humans. Clinical and epidemiological data are also taken into account when available. Abuse liability also depends upon other factors such as the formulations in which the drug becomes available, its cost, and the ease of synthesizing it.

Drug History

The starting point in the drug history is the documentation of current prescription drug use. It often is very helpful for patients to bring all current medications with them to the clinical encounter. Specific prompting is required to elicit the use of over-the-counter drugs and herbal supplements. Similarly, information about medications that are used only sporadically (e.g., sildenafil for erectile dysfunction) may not be volunteered. With cognitively impaired patients, it may be necessary to include caregivers and pharmacy records in the drug history process. Adverse reactions to drugs should be documented with specifics regarding severity. It is revealing to ask whether patients or their physicians have discontinued any medications in the past. A review of current drug profile and list of adverse effects are required for each patient encounter, both during hospital rounds and during outpatient visits, to maximize effectiveness and safety of treatment.

Prices in the BNF

Basic net prices are given in the BNF to provide an indication of relative cost. Where there is a choice of suitable preparations for a particular disease or condition the relative cost may be used in making a selection. Cost-effective prescribing must, however, take into account other factors (such as dose frequency and duration of treatment) that affect the total cost. The use of more expensive drugs is justified if it will result in better treatment of the patient, or a reduction of the length of an illness, or the time spent in hospital. Prices have generally been calculated from the net cost used in pricing NHS prescriptions in October 2010. Prices generally reflect whole dispensing packs prices for injections are stated per ampoule, vial, or syringe. The price for an extemporaneously prepared preparation has been omitted where the net cost of the ingredients used to make it would give a misleadingly low impression of the final price. In Appendix 8 prices stated are per dressing...

Shared care

Prescriptions1 should be written legibly in ink or otherwise so as to be indelible2, should be dated, should state the name and address of the patient, and should be signed in ink by the prescriber3. The age and the date of birth of the patient should preferably be stated, and it is a legal requirement in the case of prescription-only medicines to state the age for children under 12 years. 1. These recommendations are acceptable for prescription-only medicines (H) For items marked CC see also Controlled Drugs and Drug Dependence, p. 8. 2. It is permissible to issue carbon copies of NHS prescriptions as long as they are signed in ink. Prescribing by dental surgeons Until new prescribing arrangements are in place for NHS prescriptions, dental surgeons should use form FP10D (GP14 in Scotland, WP10D in Wales) to prescribe only those items listed in the Dental Practitioners' Formulary. The Act and Regulations do not set any limitations upon the number and variety of substances which the...

Pain And The Courts

Dr Hurwitz was convicted by a federal district court jury of 50 counts of distributing and conspiring to distribute controlled substances, for which he was sentenced to 25 years in prison. The thrust of the prosecution's case was that the doses of narcotics that Dr Hurwitz prescribed to his chronic pain patients were so excessively high that they were ''outside the bounds of medical practice.'' Once categorized in this way, Dr Hurwitz was (in the words of the DEA administrator) ''no different from a cocaine or heroin dealer peddling poison on the street.''63 One of the key arguments on the appeal of Dr Hurwitz's conviction was that in violation of the precedent established by the US Supreme Court in other criminal prosecutions under the Controlled Substances Act, the trial judge precluded the jury from considering evidence that the prescriptions in question were written in a good faith effort to care for these patients, and not for the purpose of drug trafficking.64 Other factors used...

Dosage in children

Prescription writing Prescriptions should be written according to the guidelines in Prescription Writing (p. 5) Inclusion of age is a legal requirement in the case of prescription-only medicines for children under 12 years of age, but it is preferable to state the age for all prescriptions for children.

Diet Initiation

Breakfast and lunch remain at one-third of the calculated calories as eggnog on day 3, but dinner increases to two-thirds of the usual allowance (still eggnog). On day 4, breakfast and lunch are also increased to two-thirds of allowance, and dinner is then given as the first full KD meal (with actual foods provided). On the fifth hospital day, the child receives a full ketogenic breakfast and is discharged to home. All children are sent home with prescriptions for urine ketosticks, additional calcium, and a sugar-free, fat-soluble vitamin and mineral supplement. Medications are left unchanged unless side effects are problematic, it is always better to use tablets or a carbohydrate-free solution whenever possible. Follow-up is arranged.


One of the pivotal papers to raise awareness of the issue of PIE, particularly in the United States, was the US Geological Survey (USGS) National Reconnaissance programme on pharmaceuticals, hormones, and other wastewater contaminants in United States streams ) 10 ) The work provided the first nationwide survey for these contaminants in the United States, and the results were, to many people, startling. The study analyzed samples from a network of 139 streams across the country for 95 organic wastewater contaminants (OWCs) including 30 veterinary and human antibiotics and prescription medications and 14 artificial and naturally occurring steroids and hormones. Out of the 95 OWCs analyzed, 82 were detected in at least one sample and at least one OWC was detected in 80 of the samples collected.


Selling prescription drugs Prescription forgery Obtaining prescription drugs from nonmedical sources Concurrent abuse of alcohol or illicit drugs Multiple nonsanctioned dose escalations Multiple episodes of prescription loss Repeatedly seeking prescriptions from other physicians or emergency departments without informing the prescriber or after warnings to desist Evidence of deterioration in function, at work, in the family, or prescription. In many cases, it will be necessary to reduce and then cease the opioid. In other cases, a more regulated supply, such as daily or weekly prescriptions, may be appropriate. An initial written consent form, indicating those factors for which supply will be weaned and ceased, will make this easier.

Oral Drug Absorption

The understanding and the prediction of oral drug absorption are of great interest for pharmaceutical drug development. Obviously, the establishment of a comprehensive framework in which the physicochemical properties of drug candidates are quantitatively related to the extent of oral drug absorption will accelerate the screening of candidates in the discovery preclinical development phase. Besides, such a framework will certainly help regulatory agencies in developing scientifically based guidelines in accord with a drug's physicochemical properties for various aspects of oral drug absorption, e.g., dissolution, in vitro in vivo correlations, biowaivers of bioequivalence studies.

Consumer Protection

One area where psychopharmacology is closely involved with the law is in the area of drug misuse. This can relate to drugs which have no recognised therapeutic properties, such as LSD, and therefore whose use can only be a misuse, or to products that have a licit indication, such as morphine, but can be misused (Glaser and Warren 1999). A controversy attends the use of cannabis products, where some products have been licensed in some countries to establish a legitimate therapeutic usage in pain and nausea. Jurisdictions generally reorganise various ways in which medicinal products can be provided (Appelbe and Wingfield 2005). The most restricted is a Prescription-Only Medicine, prescribed by a recognised medical, dental, or veterinary practitioner. The least restricted is a General Sale Medicine which can be sold in shops and supermarkets. Some countries have an intermediate category of drugs which are available without prescription under the supervision of a pharmacist.


A pharmaceutical company must make a profit if it is to continue to research and develop new medicines. Obviously to make a profit the company will need to more than recoup the costs of developing each new medicine. This requires successful marketing of the product. One might expect after the arduous path the product has so far followed that this would be the easiest stage. However healthcare costs are rising rapidly throughout the world and are under intense scrutiny. Although the mean expenditure on prescription medicines in Europe is only about 11 of healthcare costs, it is a growing fraction. Furthermore, as it is politically difficult to cut back on the healthcare employees' payroll or on hospital building programmes, restricting the medicines bill is regarded as one of the easiest areas to limit health expenditure. Therefore very significant efforts are being made by governments to, at least, slow the rise in the medicines bill . This is occurring at the very time that the costs...

Pharmaco Vigilance

Pharmacovigilance studies are sometimes classified as phase 4 trials, but are more appropriately called post-marketing surveillance studies. These are non-interventional and essentially observational with the aim of gathering more safety data about the newly licenced medicine. Various techniques can be used to gather such data such as cohort studies, case-control studies and computerised data bases which link prescriptions to ADRs. On average when a new medicine is licenced about 1500-3000 humans will have been exposed to it. If a particular adverse reaction to this new medicine only occurs in 1 in 5000 patients, then it is obvious that the pre-licencing data has little chance of detecting this. Hence pharmacovigilance is only beginning when a medicine reaches the market.


Opioid medications are also commonly prescribed for CLBP patients, although studies supporting their use are difficult to interpret given the heterogenicity of opioids studied and the small sample sizes.76,77,78 II These studies show no improvement in function even if effective at controlling pain and typically do not address sampling issues such as whether patients were opioid-naive or opioid-experienced. Systematic reviews find patients using opioids not uncommonly have histories of substance abuse.79, 80 Finally, it has to be appreciated that significant variability exists in the metabolism of these drugs highlighted by examples that normal doses can be life-threatening in certain circumstances.81 Overall, limiting use to short periods of time and favoring long-acting, scheduled opioids makes the most sense. If faced with longer-term prescribing of opioids, consider an opioid-use contract signed by the patient. It should include having one source for prescriptions, restriction of...

Chapter Overview

Certainly, the cost of medical care cannot be overlooked when considering the reasons for interest in alternative forms of medicine. Most herbal medicines are far less expensive than prescription drugs. There is danger, however, in self-medicating with herbal drugs. The old adage that he who tries to diagnose himself has a fool for a physician becomes very apropos with herbal medicine. When prescription drugs are dispensed, a patient has access to the information that is available from the physician or pharmacist. This is often not the case with herbal medicinals. In the United

Oan herb is a drug

Despite the regulations, an herbal preparation possesses the properties of a drug, albeit a mild one in many cases, and should be treated as such. It is pharmacologically active. It interacts with prescription drugs. It affects the health of the person taking it. Advertisers often tout herbs as nondrugs in an attempt to lure consumers. Pharmacists should be cog nizant of the truth that herbs are real drugs and that their patients may be self-medicating with them. This practice may affect the outcome of therapy with prescription drugs. For example, suppose a patient is stabilized on Coumadin and starts to take ginkgo. Ginkgo affects platelet-activating factor (PAF)15 and can effectively cause an overdose effect with Coumadin, and the patient can bleed. Or, suppose a patient taking a monoamine oxidase inhibitor (MAOl) decides to take St. John's wort the patient may have a toxic reaction.16 Because pharmacists often do not see what their patients are buying, this is a complex problem.

Oral Order

Prescriptions for schedule III, IV, and V medications may be telephoned to a pharmacy by a physician or by trusted staff in the same manner as a prescription for a noncontrolled substance, although it is in the physician's best interest to keep his or her DEA number as private as reasonably possible (see Preventing Diversion, below). Schedule II prescriptions may be telephoned to a pharmacy only in emergency situations. To be an emergency (1) immediate administration is necessary (2) no appropriate alternative treatment is available and (3) it is not reasonably possible for the physician to provide a written prescription prior to the dispensing.


In late 2006, an FDA advisory panel used the above data, along with findings from a total of 372 randomized, placebo-controlled antidepressant trials (involving close to 100,000 adult patients), in their decision to recommend that the black box warning be extended to cover young adults up to their mid-20s (U.S. Food and Drug Administration 2007). They reported that in patients 18-24 years of age, antidepressant use was associated with four cases of suicidal ideation per 1,000 patients treated, whereas drug therapy for patients older than 30 years was unequivocally protective against suicidality. The decision to extend the warning was made despite evidence that the initial warning might have had dangerous, unintended consequences for children and adolescents suffering from depression in the United States. Nemeroff et al. (2007) analyzed prescription data and physician surveys detailing prescription practices to identify trends in antidepressant use among children and adolescents. They...

SSRIs History

The first selective serotonin reuptake inhibitor (SSRI), fluoxetine, was introduced to the American market in 1988 (30). Other SSRIs, sertraline, paroxetine, and flu-voxamine, followed closely. Although widely used in Europe for some time, it was not until the late 1990s that another SSRI, citalopram, became available to American clinicians and later, its enantiomer, escitalopram, was introduced. By the early 1990s, the SSRIs became first-line antidepressants in clinical practice and accounted for more than half of all antidepressant prescriptions. They enjoyed unprecedented marketing success (31), had great exposure in popular literature and news, and at first were thought to be orders of magnitude superior to already existing antidepressant drugs. Indeed, SSRI compounds have a more favorable side effect profile, simpler dosing strategies, better tolerability, and thus better adherence than older antidepressants. Their relative safety in overdose, minimal cardiovascular effects, and...


We hear almost every day about the unwanted effects of prescription drugs and over-the-counter nostrums, of unsafe substances in foods, and of the perils of tobacco smoking and drinking alcohol. We cannot help but wonder why such effects occur in only a fraction of persons exposed, or why a drug that is therapeutic in one person may be ineffective, or even toxic, in another. This is the province of pharmacology. During the period in and around the 1950s, pharmacologists demonstrated, contrary to common belief, that adverse responses accompanying exposure to exogenous substances were closely tied to a person's genetic makeup (Figure 1.1). When this concept was proposed, it was not entirely new because biologists had long understood that the capacity of organisms to respond differently to the environment was genetically determined. Even so, demonstrating that heredity exerted important effects on human drug responsiveness was an innovative step that cast doubt on the notion that the...


There are no pure hydrocodone products available on the U.S. market. All FDA-approved products containing hydrocodone are combination products. Like codeine, hy-drocodone is marketed as an antitussive agent. It is available combined with the anticholinergic agent homatropine as a syrup and a tablet. The addition of the anticholinergic agent is to discourage abuse. It is also available in a delayed release suspension form (Tussionex). This formulation uses a sulfonated styrene divinylbenzene copolymer complexed with hydromorphone and chlorpheniramine that acts as a cation-exchange resin slowly releasing the drugs over a 12hour period. Hydrocodone is also marketed in combination with acetaminophen (Vicodin, Lortab) or aspirin (Lortab ASA) for the treatment of pain. The dose of acetaminophen consumed by the patient must be closely monitored, and prescriptions that allow for greater than 4 grams of acetaminophen per 24-hour period should not be dispensed.

Preventing Diversion

Ideally, the physician's full DEA number should not be preprinted on the prescription pad most prescriptions will not be for controlled substances and will not require the registration number, and anyone in possession of a valid DEA number may find it easier to commit prescription fraud. Some physicians may intentionally omit part or all of their DEA number on a prescription and instead write pharmacist call to verify or call for registration number. This practice works only when the pharmacist may independently verify the authenticity of the prescription, and patients must be advised to fill the prescription during the prescriber's office hours. Pharmacists can ascertain the likely authenticity of a physician's DEA number using an algorithm.

Chronic Pain

In Table 31.2, guidelines for prescribing drug with abuse liability in pain patients with history of addiction are outlined. Physicians should set clear rules and expectations for them and the patient and have both sign an agreement. Based on current evidence, physicians assume that patients adhering to controlled substance agreements and without obvious dependency behavior do not abuse either illicit or licit drugs. The dose of the medication should be set at the appropriate level to treat the condition and titrate as necessary. Using feedback from patient to set dose is often helpful. To prevent undertreatment of pain or treatment gaps, physician should give enough medication plus rescue doses. Patients should be asked to bring in all original medication bottles with or without medication including the date they are filled, the prescribing physician and the dispensing pharmacy, the number of pills dispensed, and the number of remaining pills. Physicians should monitor for lost or...

Opioid Overview

The important role opioids play in the treatment of pain, including non-malignant causes, is well supported (Savage 2003). However, an obstacle to effective use of opioids in pain treatment is the misunderstanding of the nature and risk of addiction when using opioids. The prevalence of drug abuse, dependence, or addiction in chronic pain patients has been stated to range from 3 to 19 . The concern of the medical community to not fuel this problem in chronic pain patients has led to less than optimal treatment of these patients. With these data, 81-97 of chronic pain patients were undertreated for fear of misuse or abuse of prescription medication.